cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA358453 | lung | .b | 2125 to 2497 | 373 to 1 | 373/374 (99 %) | 0 diff (100 %id) | |||
AA358454 | lung | .a | 2645 to 2984 | 1 to 341 | 341/342 (99 %) | 6 diff (98.3 %id) | |||
AB284127 | .a | 3 to 4495 | 1 to 4493 | H822R V840A V935L | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 4493/4494 (99 %) | 11 diff (99.8 %id) | |
AK091941 | Kidney | .b | 1 to 2102 | 2 to 2102 | R158H H194R V212A V307L | tiling clone, available from FLJ, | 2102/2102 (100 %) | 9 diff (99.6 %id) | |
AK096259 | .d | 149 to 2195 | 1 to 2047 | H46R V64A V159L | tiling clone, available from FLJ, | 2047/2047 (100 %) | 7 diff (99.7 %id) | ||
AK127461 | thalamus | .c | 1 to 3023 | 2 to 3024 | H178R V196A V291L | tiling clone, available from FLJ, | 3024/3024 (100 %) | 7 diff (99.8 %id) | |
AL832644 | human spinal cord | .a | 1251 to 4494 | 1 to 3244 | available from DKFZ, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 3244/3244 (100 %) | 11 diff (99.7 %id) | |
AW955294 | .a | 2646 to 3316 | 1 to 671 | tiling clone, | 671/672 (99 %) | 3 diff (99.6 %id) | |||
AX747268 | .b | 1 to 2102 | 2 to 2102 | R158H H194R V212A V307L | 2102/2102 (100 %) | 9 diff (99.6 %id) | |||
BC060866 | Placenta, normal | .a | 3 to 4495 | 1 to 4493 | H822R V840A V935L | available from MGC, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 4493/4494 (99 %) | 11 diff (99.8 %id) |
BE140475 | head_neck | .a | 3302 to 3611 | 312 to 4 | Submitted on the opposite strand | 309/312 (99 %) | 0 diff (100 %id) | ||
BE162719 | head_neck | .a | 2117 to 2435 | 319 to 1 | Submitted on the opposite strand | 319/319 (100 %) | 3 diff (99.1 %id) | ||
BE838070 | prostate_normal | .a | 2511 to 2843 | 338 to 4 | 335/338 (99 %) | 0 diff (100 %id) | |||
BF944756 | nervous_normal | .b | 2128 to 2252 | 1 to 128 | 128/128 (100 %) | 9 diff (93.0 %id) | |||
BG008841 | placenta_normal | .a | 1128 to 1649 | 542 to 39 | 504/542 (92 %) | 0 diff (100 %id) | |||
DA150209 | amygdala | .b | 14 to 581 | 2 to 570 | capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
DA397980 | thalamus | .c | 1 to 596 | 2 to 597 | capped | 596/596 (100 %) | 0 diff (100 %id) | ||
DB312008 | thalamus | .c | 2487 to 3023 | 538 to 1 | 538/538 (100 %) | 1 diff (99.9 %id) | |||
BX113154 | liver and spleen | .b | 2063 to 2511 | 449 to 1 | 449/455 (98 %) | 0 diff (100 %id) | |||
CN279209 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 414 to 552 | 1 to 139 | 139/139 (100 %) | 1 diff (99.3 %id) | |||
CN279210 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 415 to 999 | 1 to 584 | 584/584 (100 %) | 3 diff (99.5 %id) | |||
CN312043 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2551 to 3032 | 1 to 482 | AAA | Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) | 482/482 (100 %) | 2 diff (99.6 %id) | |
CN314410 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 3072 to 3480 | 1 to 409 | tiling clone, AAA | Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) | 409/409 (100 %) | 0 diff (100 %id) | |
CN333150 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1502 to 2118 | 1 to 616 | 616/616 (100 %) | 3 diff (99.6 %id) | |||
CN333151 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1075 to 1718 | 1 to 645 | 645/645 (100 %) | 7 diff (99.0 %id) | |||
BX331539 | Neuroblastoma Cot 10-normalized | .a | 1242 to 2029 | 1 to 790 | 790/790 (100 %) | 33 diff (95.9 %id) | |||
CV378739 | placenta_normal | .a | 1368 to 1627 | 257 to 2 | Submitted on the opposite strand | 256/257 (99 %) | 0 diff (100 %id) | ||
DW411536 | Liver | .b | 2724 to 3033 | 17 to 326 | 310/328 (94 %) | 3 diff (99.1 %id) | |||
DW423419 | Liver | .b | 1610 to 1890 | 10 to 291 | 282/291 (96 %) | 6 diff (98.0 %id) | |||
FN170297 | breast carcinoma | .b | 2264 to 2373 | 1 to 110 | 110/110 (100 %) | 0 diff (100 %id) | |||
AV684541 | hepatocellular carcinoma | .a | 2629 to 3065 | 1 to 432 | 432/434 (99 %) | 9 diff (98.0 %id) | |||
AV684569 | hepatocellular carcinoma | .a | 2629 to 3065 | 1 to 432 | 432/433 (99 %) | 9 diff (98.0 %id) | |||
AV687501 | hepatocellular carcinoma | .a | 2629 to 3050 | 1 to 419 | 419/428 (97 %) | 12 diff (97.2 %id) | |||
AV688590 | hepatocellular carcinoma | .a | 2629 to 3050 | 1 to 419 | 419/429 (97 %) | 12 diff (97.3 %id) | |||
AV688594 | hepatocellular carcinoma | .a | 2629 to 3050 | 1 to 419 | 419/428 (97 %) | 12 diff (97.2 %id) | |||
AV689780 | hepatocellular carcinoma | .a | 2629 to 3050 | 1 to 419 | 419/428 (97 %) | 13 diff (97.0 %id) | |||
AV694201 | hepatocellular carcinoma | .a | 2629 to 3050 | 1 to 419 | 419/427 (98 %) | 12 diff (97.2 %id) | |||
DA569453 | whole embryo, mainly head | .b | 1409 to 2250 | 2 to 841 | capped | 840/840 (100 %) | 4 diff (99.6 %id) | ||
DB356095 | whole embryo, mainly head | .b | 2449 to 3032 | 580 to 1 | tiling clone, | 580/583 (99 %) | 11 diff (98.2 %id) | ||
R20871 | whole brain | .a | 3217 to 3589 | 1 to 380 | 379/451 (84 %) | 18 diff (96.1 %id) | |||
R42051 | whole brain | .a | 4036 to 4505 | 475 to 1 | tiling clone, | 475/475 (100 %) | 15 diff (96.9 %id) | ||
H50647 | liver and spleen | .b | 2097 to 2496 | 19 to 426 | Submitted on the opposite strand | 408/428 (95 %) | 9 diff (97.9 %id) | ||
H50735 | liver and spleen | .b | 2099 to 2498 | 404 to 1 | Submitted on the opposite strand | 404/404 (100 %) | 4 diff (99.1 %id) | ||
H56974 | liver and spleen | .b | 2100 to 2493 | 1 to 409 | Submitted on the opposite strand | 409/416 (98 %) | 16 diff (96.2 %id) | ||
N76926 | liver and spleen | .b | 2063 to 2497 | 439 to 1 | Submitted on the opposite strand | 439/486 (90 %) | 8 diff (98.4 %id) | ||
N55540 | liver and spleen | .b | 2094 to 2514 | 1 to 426 | Submitted on the opposite strand | 426/468 (91 %) | 6 diff (98.8 %id) | ||
N67896 | cochlea, ear | .b | 3099 to 3481 | 385 to 2 | 384/385 (99 %) | 0 diff (100 %id) | |||
N99637 | liver and spleen | .b | 2517 to 2990 | 9 to 488 | tiling clone, | 480/490 (97 %) | 9 diff (98.2 %id) | ||
AA709133 | heart | .b | 3061 to 3484 | 428 to 7 | tiling clone, | 422/428 (98 %) | 0 diff (100 %id) | ||
AA680112 | liver and spleen | .b | 2093 to 2491 | 1 to 399 | Submitted on the opposite strand | 399/399 (100 %) | 1 diff (99.8 %id) | ||
AA479171 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 1804 to 2107 | 1 to 305 | 305/305 (100 %) | 2 diff (99.4 %id) | |||
AA456955 | .a | 3977 to 4494 | 520 to 1 | 520/520 (100 %) | 7 diff (98.7 %id) | ||||
AA457064 | .a | 3285 to 3644 | 1 to 363 | 363/363 (100 %) | 6 diff (98.4 %id) | ||||
AI333316 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 2004 to 2497 | 494 to 1 | 494/494 (100 %) | 1 diff (99.8 %id) | |||
AI381634 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 2036 to 2497 | 463 to 1 | 463/463 (100 %) | 2 diff (99.6 %id) | |||
AI420038 | Prostate | .b | 2077 to 2498 | 423 to 1 | 423/423 (100 %) | 1 diff (99.8 %id) | |||
AI468658 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 2217 to 2497 | 281 to 1 | 281/281 (100 %) | 0 diff (100 %id) | |||
AI674975 | Prostate | .b | 2092 to 2487 | 406 to 11 | 396/406 (97 %) | 0 diff (100 %id) | |||
AI741903 | pooled | .b | 2041 to 2496 | 456 to 1 | 456/456 (100 %) | 1 diff (99.8 %id) | |||
AI970049 | Prostate | .b | 2035 to 2499 | 465 to 1 | 465/465 (100 %) | 1 diff (99.8 %id) | |||
BI491401. matches multiple genes | cochlea, ear | .b | 2187 to 2514 | 328 to 1 | tiling clone, | also hits gene ANTXR1 | 328/335 (97 %) | 0 diff (100 %id) | |
AW020342 | cochlea, ear | .b | 2187 to 2497 | 8 to 318 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 311/318 (97 %) | 6 diff (98.2 %id) | |
AW023699 | cochlea, ear | .b | 1816 to 2222 | 8 to 413 | 406/417 (97 %) | 2 diff (99.6 %id) | |||
BI494632 | cochlea, ear | .b | 2826 to 3048 | 223 to 1 | tiling clone, fully sequenced, | Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) | 223/223 (100 %) | 2 diff (99.2 %id) | |
BI494633 | cochlea, ear | .b | 2540 to 3032 | 1 to 493 | tiling clone, fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) | 493/493 (100 %) | 1 diff (99.8 %id) | |
AW444456 | .b | 2088 to 2492 | 9 to 413 | Submitted on the opposite strand | 405/423 (95 %) | 6 diff (98.6 %id) | |||
BE300482 | choriocarcinoma, placenta | .b | 2048 to 2499 | 452 to 1 | 452/452 (100 %) | 0 diff (100 %id) | |||
BE300309 | muscle, rhabdomyosarcoma | .d | 1 to 701 | 13 to 737 | tiling clone, | 725/745 (97 %) | 36 diff (95.2 %id) | ||
AW409700. matches multiple genes | muscle, rhabdomyosarcoma | .b | 1567 to 2102 | 554 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base), also hits gene LPHN1 | 536/536 (100 %) | 1 diff (99.9 %id) | |
AW409800 | muscle, rhabdomyosarcoma | .d | 58 to 653 | 17 to 612 | tiling clone, | 596/612 (97 %) | 6 diff (99.1 %id) | ||
BE019514 | muscle, rhabdomyosarcoma | .e | 18 to 471 | 1 to 454 | tiling clone, | 454/454 (100 %) | 14 diff (97.0 %id) | ||
BE206280 | muscle, rhabdomyosarcoma | .e | 1164 to 1642 | 479 to 1 | tiling clone, | 479/479 (100 %) | 10 diff (98.0 %id) | ||
BF511862 | .b | 2088 to 2492 | 9 to 413 | Submitted on the opposite strand | 405/420 (96 %) | 8 diff (98.1 %id) | |||
BC041418 | Placenta, choriocarcinoma | .a | 1783 to 4100 | 1 to 2318 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 2318/2318 (100 %) | 5 diff (99.8 %id) | |
BE537560 | cervix | .a | 1803 to 2593 | 1 to 795 | available from MGC, | 796/952 (83 %) | 69 diff (92.8 %id) | ||
BE295315 | muscle, rhabdomyosarcoma | .d | 21 to 688 | 1 to 679 | 679/772 (87 %) | 34 diff (95.6 %id) | |||
BF204822 | muscle, rhabdomyosarcoma | .d | 60 to 747 | 1 to 684 | 684/929 (73 %) | 14 diff (98.5 %id) | |||
BC033147 | Muscle, rhabdomyosarcoma | .d | 116 to 2025 | 1 to 1910 | H46R V64A V159L | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 1910/1910 (100 %) | 6 diff (99.7 %id) |
BF304949 | muscle, rhabdomyosarcoma | .d | 115 to 765 | 1 to 640 | available from MGC, | 640/843 (75 %) | 21 diff (97.6 %id) | ||
BG825977 | muscle, rhabdomyosarcoma | .e | 1 to 665 | 1 to 665 | H46R V64A | tiling clone, | 665/693 (95 %) | 9 diff (98.8 %id) | |
BI090563 | cervix | .a | 3374 to 4108 | 1 to 736 | 736/736 (100 %) | 3 diff (99.6 %id) | |||
BQ879119 | dorsal root ganglia | .a | 1231 to 2078 | 1 to 858 | 858/916 (93 %) | 18 diff (98.1 %id) | |||
CB989254 | Human Placenta, placenta | .a | 1 to 634 | 28 to 669 | tiling clone, | 642/819 (78 %) | 22 diff (97.4 %id) | ||
CB960340 | Human Placenta, placenta | .a | 3 to 772 | 28 to 804 | 777/815 (95 %) | 23 diff (97.2 %id) | |||
CB960938 | Human Placenta, placenta | .a | 3 to 633 | 28 to 663 | AAA | 636/827 (76 %) | 14 diff (98.4 %id) | ||
CB960937 | Human Placenta, placenta | .a | 3 to 713 | 28 to 745 | 718/804 (89 %) | 24 diff (97.1 %id) | |||
CB960708 | Human Placenta, placenta | .a | 16 to 658 | 28 to 678 | 651/833 (78 %) | 15 diff (98.2 %id) | |||
CD514723 | White Matter | .a | 3192 to 3672 | 1 to 488 | 488/858 (56 %) | 12 diff (98.7 %id) | |||
CF993732 | Human Placenta, placenta | .a | 1 to 486 | 28 to 517 | 490/1033 (47 %) | 16 diff (98.5 %id) | |||
DA633276 | Kidney | .b | 1 to 470 | 2 to 473 | capped | 472/472 (100 %) | 2 diff (99.6 %id) | ||
DB320926 | Kidney | .b | 1532 to 2102 | 572 to 1 | 572/572 (100 %) | 5 diff (99.2 %id) | |||
D45628 | lung | .b | 3324 to 3484 | 1 to 161 | Submitted on the opposite strand | 161/164 (98 %) | 2 diff (98.8 %id) | ||
EB387283 | eye, optic nerve | .b | 1756 to 2497 | 1 to 742 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 742/742 (100 %) | 0 diff (100 %id) | |
NM_181712.4 | .a | 3 to 5479 | 1 to 5477 | exact | RefSeq, | 5477/5477 (100 %) | 0 diff (100 %id) | ||
DA695210 | .d | 150 to 716 | 2 to 568 | capped | 567/567 (100 %) | 6 diff (99.0 %id) | |||
DB323254 | .d | 1653 to 2195 | 545 to 1 | 545/545 (100 %) | 2 diff (99.7 %id) | ||||
DA695664 | .e | 115 to 677 | 2 to 564 | H46R V64A | tiling clone, capped | 563/563 (100 %) | 5 diff (99.2 %id) | ||
DB323269 | .e | 1641 to 2175 | 535 to 1 | tiling clone, | 535/538 (99 %) | 1 diff (99.9 %id) | |||
DA718236 | .d | 105 to 590 | 2 to 487 | capped | 486/486 (100 %) | 5 diff (99.0 %id) | |||
DA829321 | placenta | .a | 2637 to 3261 | 2 to 627 | capped | 626/628 (99 %) | 5 diff (99.3 %id) | ||
DB374097 | placenta | .a | 4177 to 4495 | 319 to 1 | 319/330 (96 %) | 0 diff (100 %id) | |||
DA831908 | placenta | .f | 1 to 684 | 2 to 685 | tiling clone, capped | 684/684 (100 %) | 10 diff (98.6 %id) | ||
DB377804 | placenta | .f | 1587 to 2066 | 481 to 1 | tiling clone, | 481/487 (98 %) | 13 diff (97.4 %id) | ||
DN997408 | breast cancer, Mammary gland (cancer tissue) | .a | 1765 to 2332 | 1 to 568 | 568/571 (99 %) | 6 diff (99.0 %id) | |||
TI_149313050 | .b | 1546 to 2497 | 1028 to 85 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 944/992 (95 %) | 17 diff (98.3 %id) | ||
BQ022752 | placenta | .b | 2253 to 2497 | 263 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 245/245 (100 %) | 0 diff (100 %id) | |
BQ025863 | placenta | .b | 2045 to 2497 | 471 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 453/453 (100 %) | 0 diff (100 %id) | |
CF541108 | lung | .b | 1840 to 2497 | 675 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 657/657 (100 %) | 1 diff (99.9 %id) | |
BM698610 | eye, fetal eyes | .a | 2318 to 2789 | 1 to 471 | 471/471 (100 %) | 3 diff (99.4 %id) | |||
BU736248 | eye, fetal eyes | .a | 3571 to 4115 | 545 to 1 | 545/545 (100 %) | 4 diff (99.3 %id) | |||
BM701638 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 1840 to 2128 | 1 to 289 | fully sequenced, | 289/289 (100 %) | 0 diff (100 %id) | ||
BU738703 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 2098 to 2515 | 418 to 1 | tiling clone, fully sequenced, | 418/418 (100 %) | 2 diff (99.6 %id) | ||
AW013913 | .a | 3192 to 3672 | 1 to 488 | This clone was ignored | 488/858 (56 %) | 12 diff (98.7 %id) | |||
CF993732 | Human Placenta, placenta | .a | 1 to 486 | 28 to 517 | 490/1033 (47 %) | 16 diff (98.5 %id) | |||
CF993732 | Human Placenta, placenta | .a | 1 to 486 | 28 to 517 | 490/1033 (47 %) | 16 diff (98.5 %id) | |||
DA633276 | Kidney | .b | 1 to 470 | 2 to 473 | capped | 472/472 (100 %) | 2 diff (99.6 %id) | ||
DB320926 | Kidney | .b | 1532 to 2102 | 572 to 1 | 572/572 (100 %) | 5 diff (99.2 %id) | |||
D45628 | lung | .b | 3324 to 3484 | 1 to 161 | Submitted on the opposite strand | 161/164 (98 %) | 2 diff (98.8 %id) | ||
EB387283 | eye, optic nerve | .b | 1756 to 2497 | 1 to 742 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 742/742 (100 %) | 0 diff (100 %id) | |
EB387283 | eye, optic nerve | .b | 1756 to 2497 | 1 to 742 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 742/742 (100 %) | 0 diff (100 %id) | |
NM_181712.4 | .a | 3 to 5479 | 1 to 5477 | exact | RefSeq, | 5477/5477 (100 %) | 0 diff (100 %id) | ||
DA695210 | .d | 150 to 716 | 2 to 568 | capped | 567/567 (100 %) | 6 diff (99.0 %id) | |||
DB323254 | .d | 1653 to 2195 | 545 to 1 | 545/545 (100 %) | 2 diff (99.7 %id) | ||||
DA695664 | .e | 115 to 677 | 2 to 564 | H46R V64A | tiling clone, capped | 563/563 (100 %) | 5 diff (99.2 %id) | ||
DB323269 | .e | 1641 to 2175 | 535 to 1 | tiling clone, | 535/538 (99 %) | 1 diff (99.9 %id) | |||
DA718236 | .d | 105 to 590 | 2 to 487 | capped | 486/486 (100 %) | 5 diff (99.0 %id) | |||
DA829321 | placenta | .a | 2637 to 3261 | 2 to 627 | capped | 626/628 (99 %) | 5 diff (99.3 %id) | ||
DB374097 | placenta | .a | 4177 to 4495 | 319 to 1 | 319/330 (96 %) | 0 diff (100 %id) | |||
DA831908 | placenta | .f | 1 to 684 | 2 to 685 | tiling clone, capped | 684/684 (100 %) | 10 diff (98.6 %id) | ||
DB377804 | placenta | .f | 1587 to 2066 | 481 to 1 | tiling clone, | 481/487 (98 %) | 13 diff (97.4 %id) | ||
DN997408 | breast cancer, Mammary gland (cancer tissue) | .a | 1765 to 2332 | 1 to 568 | 568/571 (99 %) | 6 diff (99.0 %id) | |||
DN997408 | breast cancer, Mammary gland (cancer tissue) | .a | 1765 to 2332 | 1 to 568 | 568/571 (99 %) | 6 diff (99.0 %id) | |||
TI_149313050 | .b | 1546 to 2497 | 1028 to 85 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 944/992 (95 %) | 17 diff (98.3 %id) | ||
BQ022752 | placenta | .b | 2253 to 2497 | 263 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 245/245 (100 %) | 0 diff (100 %id) | |
BQ025863 | placenta | .b | 2045 to 2497 | 471 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 453/453 (100 %) | 0 diff (100 %id) | |
CF541108 | lung | .b | 1840 to 2497 | 675 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 657/657 (100 %) | 1 diff (99.9 %id) | |
BM698610 | eye, fetal eyes | .a | 2318 to 2789 | 1 to 471 | 471/471 (100 %) | 3 diff (99.4 %id) | |||
BM698610 | eye, fetal eyes | .a | 2318 to 2789 | 1 to 471 | 471/471 (100 %) | 3 diff (99.4 %id) | |||
BU736248 | eye, fetal eyes | .a | 3571 to 4115 | 545 to 1 | 545/545 (100 %) | 4 diff (99.3 %id) | |||
BU736248 | eye, fetal eyes | .a | 3571 to 4115 | 545 to 1 | 545/545 (100 %) | 4 diff (99.3 %id) | |||
BM701638 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 1840 to 2128 | 1 to 289 | fully sequenced, | 289/289 (100 %) | 0 diff (100 %id) | ||
BM701638 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 1840 to 2128 | 1 to 289 | fully sequenced, | 289/289 (100 %) | 0 diff (100 %id) | ||
BU738703 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 2098 to 2515 | 418 to 1 | tiling clone, fully sequenced, | 418/418 (100 %) | 2 diff (99.6 %id) | ||
BU738703 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 2098 to 2515 | 418 to 1 | tiling clone, fully sequenced, | 418/418 (100 %) | 2 diff (99.6 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |